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Introduction
EpCAM has been long known as a tumor-associated antigen 
highly expressed in a variety of carcinomas (Koprowski et al., 
1979). It is used as a marker for aggressive tumors, and has been 
considered as a potential target for immunotherapy (Osta et al., 
2004). In human and mouse, EpCAM is expressed in embry-
onic epithelia, but the levels usually drop as cells reach terminal 
differentiation  (Trzpis  et  al.,  2007).  Enhanced  expression  of   
EpCAM is associated with active proliferations of neoplastic   
or normal tissues (de Boer et al., 1999). The protein can act as   
a homophilic Ca
2+-independent cell–cell adhesion molecule   
(Litvinov et al., 1994). It is not structurally related to any of   
the major families of CAMs, but a potential link to the actin cyto-
skeleton via -actinin has been documented (Balzar et al., 
1998). Thus, it was initially proposed that enhanced proliferation 
and migration in cells expressing high levels of EpCAM resulted 
from sequestering -catenin away from E-cadherin (Litvinov et al., 
1997). However, a recent study has shown that EpCAM is re-
quired to maintain the integrity and plasticity of the zebrafish 
developing epidermis where it works in partial redundancy   
with E-cadherin to promote cell–cell adhesion (Slanchev et al., 
2009). Another study indicates that the enhancing effect of   
EpCAM on proliferation rates of carcinoma may in fact largely 
rely on a signaling activity of its intracellular domain (Münz   
et al., 2004; Maetzel et al., 2009). This short segment can   
be cleaved and is then able to form a complex with FHL2,   
-catenin, and Lef-1 that induces gene transcription of onco-
genes such as C-myc and cyclins A/E. Thus, the role of EpCAM 
in cell–cell adhesion and the relative contributions of its poten-
tial adhesive and signaling activities in morphogenesis and pro-
liferation remain unclear.
Xenopus  gastrulation  is  an  established  model  to  study 
morphogenetic movements. During this phase of development, 
the embryo undergoes massive reorganization. Because there is 
very little cell division and no increase in total cell mass at this 
stage, the whole process relies purely on rearrangement of pre-
existing tissues. In particular, the ectoderm thins and expands to 
eventually cover the whole embryo (epiboly), while the meso-
derm moves inside the embryo through involution, and migrates 
along the inner surface of the ectoderm (blastocoel roof [BCR]). 
E
pithelial  cell  adhesion  molecule  (EpCAM)  is  best 
known as a tumor-associated protein highly ex-
pressed in carcinomas. The function of this cell 
surface  protein  during  embryonic  development  and  its 
potential role in cancer are still poorly understood. We 
identified EpCAM in a gain-of-function screen for inducers 
of abnormal tissue mixing during gastrulation. Elevated 
EpCAM levels in either the ectoderm or the mesoderm con-
fer “invasive” properties to cells in both populations. We 
found that this phenotype represents an “overstimulation” 
of an essential activity of EpCAM in controlling cell move-
ments during embryonic development. Surprisingly, this 
property is independent of the putative adhesive func-
tion of EpCAM, and rather relies on a novel signaling 
function  that  operates  through  down-regulation  of   
PKC  activity.  We  show  that  inhibition  of  novel  PKCs   
accounts entirely for the invasive phenotype induced by 
abnormally high levels of EpCAM as well as for its nor-
mal function in regulating cell rearrangement during   
early development.
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Figure 1.  Identification of EpCAM as inhibitor of the ectoderm–mesoderm boundary. (A) Diagram of an early Xenopus gastrula (stage 10.5). Curved   
arrow indicates direction of mesoderm involution. (A) Test for disruption of the ectoderm–mesoderm boundary (Brachet’s cleft) by dorsal injection of mRNA 
(green). (B and B) Sagittal views of the dorsal region of embryos injected with control GFP mRNA (B) or EpCAM mRNA (B). The boundary (arrowheads) 
is disrupted in the posterior region (arrow) of EpCAM-overexpressing embryos. Cryosections were stained with anti–C-cadherin antibody. Note that exposure 
has been increased for controls to match the staining intensity of EpCAM-expressing samples. For proper comparison of C-cadherin levels, see Fig. 3.   
(C) Ubiquitous expression of endogenous EpCAM in all three germ layers, ectoderm (ecto), mesoderm (meso), and endoderm (endo) of the early gastrula. 
Arrowheads point to Brachet’s cleft. (C–C) Detail of ectoderm from cryosections of control MO (COMO) and EpCAM MO-injected embryos stained with 
anti-EpCAM antibody, demonstrating antibody specificity. (D–F) Reconstituted boundaries made of dissected wild-type mesoderm sandwiched between 647 EpCAM signaling regulates morphogenesis • Maghzal et al.
original assay, we introduced an intermediate “fused” category 
corresponding to a partial loss of separation behavior (blurred 
boundary, yet explants still bulging out of the BCR). This pheno-
type is observed at low frequency with wild-type mesoderm.
Consistent with the cleft phenotype observed in whole 
embryos, we found significant mixing upon EpCAM over- 
expression. Remarkably, EpCAM caused the same phenotype when 
expressed either in the BCR or in the mesoderm (Fig. 2, B and C). 
Simultaneous expression in both tissues did not strengthen the 
phenotype (unpublished data). The effect appeared dose depen-
dent, peaking around an mRNA dose of 250–300 pg/injection.
We also examined reconstituted boundaries obtained by 
juxtaposition of dissected BCRs and mesoderm by cryosectioning 
and immunofluorescence (Fig. 1 D). Compared with control bound-
aries (Fig. 1 E), the interface between EpCAM-overexpressing 
BCRs and mesoderm was more irregular (Fig. 1 E), and cells 
from one tissue could be found to intrude into the other tissue 
(Fig. 1 E). In a few cases single ectodermal cells were even 
found isolated in the middle of the mesoderm explants (not   
depicted), which is never observed for wild-type tissues. Quanti-
tative analysis of “rectilinearity” confirmed that upon EpCAM 
overexpression the interface departed very significantly from the 
relative straightness measured in controls (Fig. 1 F).
Endogenous EpCAM is expressed in both 
ectoderm and mesoderm
EpCAM transcripts are present maternally and throughout   
development (unpublished data). We determined EpCAM pro-
tein localization by immunofluorescence on cryosections using an 
antibody raised against its cytoplasmic tail. Unlike the epithelial-
specific expression reported in mammalian embryos and adult 
tissues, Xenopus EpCAM is ubiquitously expressed in the   
gastrulating embryo (Fig. 1 C). Some regional differences were 
observed, levels being highest in the ectoderm and lowest in the 
endoderm, but such differences may mostly reflect the default 
distribution of maternally inherited components, as a graded 
distribution is also observed for C-cadherin (Fig. 1 B) and for   
a variety of other proteins (unpublished data). Interestingly,   
EpCAM was slightly but reproducibly enriched at the cleft (arrow-
heads). EpCAM staining was strongly decreased in embryos   
injected with morpholino antisense nucleotides targeting both 
EpCAM alleles (EpCAM MO), demonstrating the specificity of 
the antibody (Fig. 1, C–C).
EpCAM-induced mixing is mediated by its 
cytoplasmic domain
To determine which EpCAM domains were required for induc-
tion of mixing, deletion mutants of EpCAM lacking the extra-
cellular domain (E) or the cytoplasmic tail (C) were tested, 
We are particularly interested in the mechanisms that maintain 
the mesoderm separated from the overlying BCR, which is es-
sential for proper gastrulation to proceed. This system is also 
more of interest as it deals with interactions between prototypical 
forms of epithelial and mesenchymal tissues. The ectoderm–
mesoderm boundary can be particularly well studied in Xenopus, 
where it can be reconstituted in an in vitro assay using tissue 
explants (Winklbauer and Keller, 1996; Wacker et al., 2000). 
On the mesodermal side, the control of separation seems to de-
pend in part on a still poorly characterized noncanonical Wnt 
pathway leading to PKC activation (Winklbauer et al., 2001). 
An interaction between the Wnt receptor Frizzled-7, the proto-
cadherin PAPC, and the ankyrin repeat domain protein 5 xANR5, 
as well as downstream RhoA and Rho kinase appear to be in-
volved (Hukriede et al., 2003; Medina et al., 2004; Chung et al., 
2007). Information is lacking about the mechanisms regulating 
separation on the ectodermal side.
We have identified the Xenopus orthologue of EpCAM in 
a gain-of-function screen to identify gene products that cause 
aberrant ectoderm–mesoderm tissue mixing at gastrula stages. 
We show that the overexpression of EpCAM in either the ecto-
derm or the mesoderm causes both tissues to mix. More gener-
ally, we show that EpCAM levels crucially regulate movements 
of cells in embryonic tissues. We demonstrate that this effect is 
not due to an adhesive function of EpCAM, but to a signaling 
activity involving novel PKC isoforms.
Results
Identification of Xenopus EpCAM as a 
promoter of cell mixing between  
ectoderm–mesoderm
We identified a Xenopus orthologue of human EpCAM in a gain-
of-function  screen  for  gene  products  perturbing  the  ectoderm– 
mesoderm boundary, called Brachets’ cleft. When EpCAM 
mRNA was injected in the dorsal region (Fig. 1 A, green area), 
the embryos displayed a significant reduction of the poste-
rior part of cleft (Fig. 1, B–B). BLAST search revealed that 
Xenopus laevis has two closely related EpCAM genes. Their 
amino acid sequences are highly similar to each other and to 
EpCAM from other vertebrate species (Fig. S1). All subsequent 
experiments were performed using constructs based on the   
EpCAMa clone originally identified in our screen.
To analyze the effect of EpCAM on tissue mixing, we 
used a well-established in vitro assay (Wacker et al., 2000), 
where dissected explants are pressed against a blastocoel roof 
(BCR), which is constituted of ectoderm (Fig. 2 A). Explants   
of ectodermal origin readily mix in the BCR, whereas wild-
type mesoderm explants stay out. Note that compared with the 
two injected BCRs, analyzed by cryosectioning and immunofluorescence. (D) Diagram of the assay. (E–E) Examples of a control boundary (E) and of the 
irregular interfaces observed between wild-type mesoderm and EpCAM-overexpressing BCR (E, E). Membrane GFP was coexpressed as tracer. Cell 
contours were visualized using an anti–-catenin (red) and injected ectodermal cells with anti-GFP ab (green). (F) Quantification of boundary straightness 
(see Materials and methods), represented in box plots (50% of the data are within the box, the median is represented by a horizontal line, the whiskers 
indicate the maximum and minimum value, without outliers, and the single dots the outliers). 1 corresponds to a perfectly rectilinear boundary, high values 
to convoluted lines, reflecting tissue mixing. EpCAM and its E mutant caused significant mixing compared with controls (P < 0.001, Tukey-HSD test). 
Numbers on top represent number of fields/number of sandwiches (from three independent experiments).
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We further dissected the sequence requirements for this 
activity using a series of E mutants (Fig. S2). We determined 
that a short basic segment (RRKKGKYR) is sufficient for   
EpCAM function, and mutations within this cluster point to a re-
quirement for specific residues (Fig. S2). The same segment of 
human EpCAM has been reported to bind -actinin (Balzar   
et al., 1998). However, we failed to reproduce this interaction 
with the cytoplasmic tail of Xenopus EpCAM (unpublished data).
both in the BCR and in the mesoderm (Fig. 2 D). E, but not 
C, induced mixing as efficiently as wild-type EpCAM, in 
both tissues. The mixing activity of the E mutant was also 
observed on sections of reconstituted boundaries (Fig. 1 F). 
These surprising results showed that the homophilic binding 
and adhesive function of EpCAM were dispensable for the 
mixing phenotype and suggested that signal transduction might 
be involved.
Figure  2.  EpCAM  induces  ectoderm–meso-
derm tissue mixing. (A) Diagram of the in vitro 
tissue  separation  assay.  mRNA  is  injected 
animally at the 2-cell stage for BCR expression 
and dorsally at the 4-cell stage for mesoderm 
expression. At stage 10+, explants and BCRs 
are dissected and combined, and the degree 
of separation is scored as “out” (complete sep-
aration), “fused,” or “mixed.” (B) Roof assay 
of  control  GFP-expressing  and  EpCAM-over-
expressing mesoderm on wild-type BCRs. The 
three EpCAM-overexpressing mesoderms, dis-
tinguishable thanks to their lighter color, have 
mixed with the BCR, whereas control explants 
have remained out. (C) Quantification of tissue 
mixing induced by EpCAM in the BCRs or in 
the mesoderm. mRNA amounts/injection are 
indicated. -Gal and membrane GFP mRNAs 
were  used  as  controls.  (D)  The  extracellular 
domain of EpCAM is dispensable for induc-
tion of tissue mixing. Quantification of tissue 
mixing upon expression in the BCR (C) or the 
mesoderm  (D)  of  full-length  EpCAM  (FL),  or 
mutant constructs lacking the cytoplasmic tail 
(C) or the extracellular domain (E). In both 
tissues, the cytoplasmic tail is required for ac-
tivity, but the extracellular domain is dispens-
able. Numbers on top indicate total number   
of explants/number of experiments. * and **,   
P < 0.05 and P < 0.01, respectively, compared 
with controls (Student’s t test).649 EpCAM signaling regulates morphogenesis • Maghzal et al.
could both induce mixing, when expressed in either tissue, sug-
gesting that the effect on tissue separation was uncoupled from 
the effect on cadherin levels. This is inconsistent with a cell-
sorting mechanism based on classical differential adhesion.
EpCAM stimulates “intratissular”  
cell movements
We wondered whether EpCAM might regulate a different prop-
erty common to both ectodermal and mesodermal cells, perhaps 
the ability of cells to move among other cells. To address this 
question, we looked at “intratissular” movements (Fig. 4 A) in a 
“sandwich” prepared by pressing against each other two BCRs, 
one of which was manipulated, the other one wild type. After a 
2-h incubation, the sandwich was fixed and the position of the 
cells analyzed on cryosections. The rationale was that if cells 
move relative to their neighbors, the initial straight interface cre-
ated by the apposition of the two BCRs would become progres-
sively more irregular, and a mosaic pattern could eventually appear. 
Tissue mixing does not correlate with 
cadherin stabilization
In zebrafish embryos mutant for EpCAM, E-cadherin expres-
sion in ectodermal cells is decreased (Slanchev et al., 2009).   
We similarly found that EpCAM-overexpressing cells had 
strongly increased levels of C-cadherin, the major cadherin ex-
pressed in Xenopus gastrulating embryos (Fig. 3). Importantly, 
this increase was observed in both ectoderm (Fig. 3, A, B, and G) 
and mesoderm (Fig. 3, E and F). E expression had a differ-
ent effect: although total levels were not affected (Fig. 3 G), two 
different anti-cadherin antibodies showed significant reduction 
of the cell membrane staining (Fig. 3, D and D). We have not 
been able to determine the cause of this lower signal, possibly 
due to more diffused membrane distribution, increased internal-
ization, or decreased antibody accessibility. Note that the de-
creased cadherin staining is consistent with the fact that, unlike 
wild type, E caused cell dissociation at later stages (unpub-
lished data). Despite these differences, wild-type and E EpCAM 
Figure 3.  C-Cadherin levels are increased by wild-type EpCAM but not by E EpCAM. (A–F) Sections of control membrane GFP, wild-type EpCAM, or E 
EpCAM-expressing tissues (200 pg mRNA/injection) stained for C-cadherin. (C and D) Double staining using mouse monoclonal 5G5 (C and D) or rabbit 
polyclonal CE antibodies (C and D). Note that exposure has been increased in C and D compared with A and B. (E) Western Blot comparing C-cadherin 
levels in control GFP- and EpCAM or E-expressing ectoderm explants.JCB • VOLUME 191 • NUMBER 3 • 2010   650
Figure 4.  EpCAM stimulates cell migration within the ectodermal tissue. (A) Schematic representation of a migration assay in ectoderm explants. 
Sandwiches were produced by combining wild-type uninjected BCRs with BCRs injected with various mRNAs coding for membrane GFP, EpCAM-MT (see 
Fig. S2) or E, or with EpCAM MO or COMO (coinjected with membrane GFP mRNA to trace injected cells). The degree of mixing was scored by determin-
ing the relative position of individual injected cells, immunostained for GFP or Myc, at the interface with wild-type cells. (B–D) Examples of sandwiches 
with BCRs expressing control membrane GFP, and low and high levels of EpCAM. (E) Illustration of the four categories used to score cell migration: cells 
protruding less than 1/2 cell diameter relative to their neighbors (nonprotr.), cells protruding between 1/2 and 1 diameter (0.5–1), or more than one cell 
diameter (>1), and cells entirely surrounded by wild-type cells (single cells). (F–H) Quantification. Cells moderately overexpressing EpCAM tended to mi-
grate significantly more, whereas cells with high EpCAM levels remained more compacted. Cells expressing E also showed increased migration, for both 
mRNA doses tested. On the contrary, cells depleted of EpCAM (EpCAM MO) remained significantly more compact. Numbers on top indicate total number 
of explants/number of experiments. * and **, P < 0.05 and P < 0.01, respectively, compared with controls (Student’s t test; see Materials and methods).651 EpCAM signaling regulates morphogenesis • Maghzal et al.
(Fig. 6 B), dnTCF had no effect on EpCAM-induced tissue mixing 
(Fig. 6 A), demonstrating that -catenin/TCF signaling is not 
involved in this phenotype.
EpCAM operates via down-regulation of 
PKC activity
PKC signaling in the mesoderm has been implicated at the ecto-
derm–mesoderm boundary downstream of frizzled 7 (Winklbauer 
et al., 2001). Specifically, frizzled 7 depletion in the mesoderm 
caused tissue mixing, which could be rescued by overexpression 
of PKC- (and thus presumably PKC overactivation). We there-
fore sought to determine whether EpCAM-induced mixing may 
be related to PKC. We first attempted to rescue separation by   
directly activating PKC using the phorbol ester phorbol-12- 
myristate-13-acetate (PMA). A short pretreatment of EpCAM- 
expressing mesoderm explants with a low concentration of PMA 
efficiently rescued separation (Fig. 6 C). Similarly, PMA treat-
ment of EpCAM-overexpressing BCRs also rescued separation 
(Fig. 6 E). Furthermore, inhibition of PKC in wild-type tissues by 
pretreatment of either mesoderm explants or the BCR with bis-
indolylmaleimide (Bis1), a specific inhibitor of classical (, , ) 
and novel PKC isoforms (, ) phenocopied EpCAM-induced 
mixing (Fig. 6, F and G). We asked whether the epiboly pheno-
type observed upon EpCAM depletion may also be related to PKC   
activation: normal epiboly was fully rescued by treating EpCAM 
MO embryos with Bis1 (Fig. 5, G and H). Moreover, PMA treat-
ment of wild-type embryos induced a thicker BCR (Fig. 5 I). 
Thus, the role of endogenous EpCAM in early development can 
be entirely accounted for by regulation of PKC activity.
That EpCAM negatively regulates PKC activity was di-
rectly assessed using an antibody recognizing phosphorylated 
PKC substrates (Fig. 7). This antibody stained multiple struc-
tures in ectoderm cells, with prominent signals at the cell pe-
riphery, at the nuclear membrane, and inside the nuclei (Fig. 7 A). 
EpCAM MO–injected BCRs (Fig. 7 B) showed a much more 
intense staining than controls, which was drastically decreased by 
treatment with Bis1 (not depicted) or chelerythrine chloride 
(another general PKC inhibitor, Fig. 7 C). The effect of EpCAM 
depletion on p-PKC substrates was confirmed on Western blots, 
with a strong increase in several major bands (not depicted).
To determine which PKC isoforms acted downstream   
of EpCAM, we used a panel of specific inhibitors to rescue 
EpCAM MO–induced epiboly defects. Because Bis1 and PMA 
inhibit/activate both classical (, , ) and novel (, ), but not 
atypical isoforms, we focused mainly on the first two classes. 
Each inhibitor was titrated, and the data from the most effec-
tive concentration (mostly about twofold above the IC50) are 
shown. The results clearly pointed to novel PKC isoforms be-
cause two specific inhibitors, a PKC- inhibitor peptide and a 
dominant-negative  PKC-,  both  caused  ectoderm–mesoderm 
mixing (Fig. 6 E) and rescued normal epiboly as efficiently as Bis1 
or chelerythrine chloride (Fig. 5 J). Calphostin C, which has a 
preference for novel over classical PKCs, also fully rescued epib-
oly (Fig. S3). Inhibitors of classical PKC, PKC-20-28, Gö6976, 
and Ro-32-0432, had only weak effects, suggesting a minor 
contribution from the classical isoforms (Fig. 5 J and Fig. S3), 
and an inhibitor of atypical PKCs had no effect (Fig. 5 J). 
The position of the manipulated cells at this interface was scored 
using a scale of increasing mobility, from “nonprotruding” (i.e., 
straight boundary) to “single cells” (i.e., mosaic distribution; 
Fig. 4 E). Because EpCAM-induced ectoderm–mesoderm mixing 
had shown to peak around 250 pg/injection, we tested two con-
centrations, 200 and 600 pg. The patterns observed were striking 
(Fig. 4, B–D): compared with GFP controls, many more cells 
mildly overexpressing EpCAM had moved away and were found 
as single cells in the wild-type half of the sandwich (Fig. 4 E). 
Single and protruding cells added together were also signifi-
cantly more numerous. The highest amount of EpCAM, how-
ever, had the opposite effect: the boundary remained straighter 
than in the controls (Fig. 4, D and E). Thus, EpCAM displays a 
bimodal activity, stimulating cell movements at moderate levels, 
but decreasing it at higher levels, fully consistent with the results 
of the mesoderm-BCR assays.
We found that the E mutant could also stimulate migra-
tory activity (Fig. 4 E) when expressed at levels that induced   
efficient tissue mixing (40 pg, Fig. 2). However, stronger ex-
pression did not lead to compaction as observed with wild-type 
EpCAM: on the contrary, migration increased at 200 pg mRNA 
(Fig. 4 E). Higher levels caused the disaggregation of ectoderm 
cells (not depicted).
Depletion of endogenous EpCAM interferes 
with ectoderm cell rearrangement
EpCAM depletion did not cause obvious defects in ectoderm–
mesoderm boundary formation (unpublished data), but the BCR 
of the early gastrula was significantly thicker than normal (Fig. 5, 
A–D and H), indicating that epiboly, a process that involves   
radial intercalation and leads to expansion and thinning of the 
tissue (Keller, 1980), was impaired. The phenotype was fully 
rescued by coinjection of mRNA coding for full-length EpCAM 
but lacking 5 UTR recognized by the morpholinos (Fig. 5,   
E and H). In zebrafish, a similar phenotype has been reported, 
and has been mostly discussed based on the presumed adhesive 
function of EpCAM (Slanchev et al., 2009). Here, we directly 
addressed this issue by testing the ability of E to rescue epib-
oly in the EpCAM MO–injected embryos. E could fully res-
cue a normal BCR (Fig. 5, F and H), demonstrating that the 
extracellular domain, and thus homophilic binding, are dispens-
able for this function.
EpCAM depletion also inhibited cell movement in the 
BCR sandwich assay: EpCAM-depleted BCRs remained sig-
nificantly more compact, maintaining a sharp boundary with the 
apposing wild-type BCR (Fig. 4 H).
EpCAM-induced tissue mixing is 
independent of -catenin signaling
Because the EpCAM cytoplasmic tail can act as a signal trans-
ducer together with -catenin and Lef1/TCF (Maetzel et al., 
2009), we tested the ability of a dominant-negative xTCF3 con-
struct (dnTCF) to interfere with EpCAM-induced mixing. The 
efficiency  of  dnTCF  to  block  -catenin/TCF-Lef  signaling   
was verified using the well-established axis-duplication assay   
(Molenaar et al., 1996; Fagotto et al., 1997; Zeng et al., 1997). At 
doses that completely blocked -catenin–induced axis duplication JCB • VOLUME 191 • NUMBER 3 • 2010   652
Figure 5.  Block of BCR epiboly upon EpCAM depletion and rescue by E EpCAM or by PKC inhibition. (A and B) Cross sections of early gastrula BCRs 
from embryos injected with control MO (COMO) and EpCAM MO. Sections were stained with anti–C-cadherin antibody. (C–F) Higher magnification views 
of BCRs from controls, EpCAM MO, and rescue by full-length EpCAM or E mRNA coinjection. Arrows indicate the outer and inner surfaces of the BCRs. 
Control BCRs were 2–3 cell layers thick, including the outer layer, which does not undergo radial intercalation. EpCAM MO BCRs were much thicker. 
Normal morphology was rescued by EpCAM or E. (G) BCR of an embryo injected with EpCAM MO and incubated for 2 h with the PKC inhibitor Bis1 
before fixation. (H) Quantification of BCR thickness (counted as number of inner cell layers, excluding the outer layer). **, P < 0.01 compared with EpCAM 
MO (Student’s t test). (I) Impaired epiboly upon treatment with PMA or Coleon U (Col U), a specific inhibitor of novel PKCs. **, P < 0.01 compared with 
controls. (J) Effect of selective PKC inhibitors on epiboly of EpCAM MO-injected embryos. **, P < 0.01 compared with EpCAM MO. Activator/inhibitor 
concentrations are listed in Materials and methods. Numbers on top indicate total number of embryos/number of experiments.653 EpCAM signaling regulates morphogenesis • Maghzal et al.
Figure 6.  EpCAM-induced tissue mixing is independent of -cat/TCF signaling but involves down-regulation of PKC signaling. (A) Effect of dominant-
negative xTCF (dnTCF) coexpression. dnTCF does not rescue EpCAM-induced cell mixing. (B) Effect of dnTCF on secondary axis induction by -catenin. 
dnTCF completely abolished double-axis induction. **, P < 0.01, Student’s t test. (C) Rescue of EpCAM-induced mixing by PMA and Coleon U (ColU). 
EpCAM overexpressing BCRs or mesoderm explants were incubated in the presence of PMA/Coleon U for 15 min before the assay. * and **, P < 0.05 
and P < 0.01, respectively, compared with EpCAM alone. (D) PKC inhibition interferes with tissue separation. Wild-type BCRs or mesoderm explants were 
preincubated for 15 min in the presence of 500 nM Bis1. The assay was then performed in the absence (second column) or in the presence (third column) 
of Bis1. * and **, P < 0.05 and P < 0.01, respectively, compared with controls. (E) Effect of PKC isoform-specific inhibitors on tissue separation. Inhibitors 
were added to the BCRs 15 min before assembling the assay. In the case of Gö6976, the assay was also then performed in the continuous presence of the 
inhibitor (last column). * and **, P < 0.05 and P < 0.01, respectively, compared with controls. Numbers on top indicate total number of explants/number 
of experiments.JCB • VOLUME 191 • NUMBER 3 • 2010   654
The role of novel PKCs was further demonstrated by the fact 
that Coleon U, a specific activator of novel PKCs (Coutinho   
et al., 2009), induced BCR thickening, phenocopying EpCAM 
depletion (Fig. 5 J). Novel PKCs also appeared crucial for 
ectoderm–mesoderm separation: the PKC- inhibitor and the 
dominant-negative PKC- induced mixing, whereas Gö6976 
had no effect (Fig. 6 F). Furthermore, Coleon U treatment of 
EpCAM-overexpressing BCRs fully rescued tissue separa-
tion (Fig. 6 D).
We also examined the effect of the various inhibitors on 
the  enhanced  phospho-PKC  substrate  staining  observed  in   
EpCAM-depleted BCRs. The signal was reduced to various 
Figure  7.  PKC  overactivation  in  EpCAM-
depleted  embryos,  and  enhanced  activation 
at  the  ectoderm–mesoderm  boundary.  (A–F) 
Cryosections  of  ectoderm  explants  stained 
with an antibody recognizing phosphorylated 
PKC substrates. (A) Control, with weak signal 
at  the  cell  periphery  (large  arrows),  in  the 
nucleus (small arrow), and at the nuclear mem-
brane (arrowheads). Note that not all nuclei 
are visible on one section. (B) Bright signal in 
EpCAM-depleted cells, including a prominent 
signal at the periphery (large arrows) and at the 
nuclear membrane (arrowheads). (C–E) Strong 
decrease after treatment of EpCAM-depleted 
explants  with  chelerythrine  chloride  (ChelCl, 
inhibitor of classical and novel PKCs), PKC- 
peptide inhibitor, or expression of dominant-
negative PKC-. (F) Partial selective decrease 
(mostly  cytoplasm  and  nuclear  membrane) 
after treatment with Gö6976 (classical PKCs). 
(G and G) Dorsal region of stage 10.5 whole-
embryo section double-stained for C-cadherin 
(G, red channel), and phospho-PKC substrates 
(G, green channel; including enlarged areas 
and corresponding pseudocolors). Nuclei were 
counterstained  with  Hoechst  (not  depicted). 
Exposure is higher than for panels A–F. The 
signal  tends  to  be  enriched  along  parts  of 
Brachet’s cleft (arrowheads). Other bright sig-
nals correspond mainly to nuclei and mitotic 
structures (small arrows).
degrees by inhibitors of both classical and novel PKCs (Fig. 7, 
C–F). Different inhibitors preferentially decreased the signal at 
specific subcellular locations, confirming that various PKC iso-
forms have distinct sets of targets. For instance, Gö6976 elimi-
nated most of the nuclear membrane signal, but had little effect 
on the signal at the cell periphery. Globally, however, PKC- 
and - inhibitors had the strongest effect, lowering the signal 
close to the levels of wild-type cells. These results indicate that 
EpCAM depletion causes a general increase in both classical 
and  novel  PKC  activities.  Nevertheless,  the  novel  isoforms 
seem to play a major functional role in tissue separation and 
epiboly. We stained sections of whole embryos, and observed a 655 EpCAM signaling regulates morphogenesis • Maghzal et al.
It had been so far difficult to reconcile the proposed role of 
EpCAM as an adhesion molecule (Trzpis et al., 2007) with the 
observed cell phenotypes, in particular its stimulatory effect on 
in vitro cell migration (Osta et al., 2004) and its requirement   
in vivo to enable cells to rearrange during epiboly (Slanchev et al., 
2009). Our data provide a different view of EpCAM function in 
morphogenesis. Indeed, the observed loss- and gain-of-function 
phenotypes (epiboly phenotype, increased migration within the 
ectoderm, ectoderm–mesoderm mixing in both directions) can 
all be attributed to a single activity of EpCAM, which does not 
require its extracellular domain. This activity appears to impinge 
on a PKC-dependent pathway: (1) PKC inhibition fully rescues 
the loss-of-function epiboly phenotype and mimics the gain- 
of-function tissue mixing phenotype; (2) PKC activation interferes 
with epiboly and rescues the ability of an overexpressing EpCAM 
tissue to maintain a boundary; and (3) EpCAM levels negatively 
affect endogenous PKC activity. We have established that novel 
PKCs play a major role in tissue separation and epiboly. Together 
with data implicating PKC- in convergence extension (Kinoshita 
et al., 2003), novel PKCs emerge as crucial regulators of mor-
phogenesis. We found no evidence for a role of classical, calcium- 
activated PKC-/ at the cleft, at least in the most downstream 
events activated/inhibited during our short pretreatments. It is 
thus possible that PKCs are involved at two levels: classical PKCs 
in an upstream frizzled calcium-dependent pathway (Sheldahl   
et al., 1999; Medina et al., 2004), and novel PKCs in regulating 
more proximally the actin cytoskeleton. Note however that nei-
ther the role of classical PKC nor a direct requirement for cal-
cium in PKC activation have been demonstrated in the context   
of tissue separation. Previous rescues have used PKC- over-
expression (Winklbauer et al., 2001), which may have resulted 
from global, nonspecific PKC overactivation. Yet, considering 
the many potential activities of PKCs, it is even possible that 
each isoform has multiple roles, of which we detect only the 
ones related to the most obvious phenotypes and/or to those most 
sensitive to modulation of PKC activity.
We show that PKC function is not restricted to the meso-
derm, as previously assumed, and may in fact repress a general 
property of embryonic cells to move actively among other cells. 
Presumably, the establishment of a boundary requires this motile 
activity to be tamed. The widespread localization of PKC-
phosphorylated substrates and the global deregulation observed 
in EpCAM-depleted ectoderm explants suggest that this control 
is in place in all cells/tissues, although the enhanced signal de-
tected along the cleft hints at an additional local activity specifi-
cally at the boundary, an interesting possibility to be addressed 
in the future.
Despite EpCAM being expressed at significant levels in 
the mesoderm and enriched at the cleft, loss of EpCAM func-
tion did not cause obvious defects in mesoderm involution or in 
tissue separation (unpublished data). Whether the low levels left 
at this stage in MO-injected embryos are sufficient or whether 
EpCAM is not required in this context remains to be solved. 
Clearly however, a tight regulation of EpCAM levels is crucial 
for gastrulation: decreasing levels in the BCR lead to impaired 
cell mobility and block epiboly, whereas higher levels stimu-
late cell mobility and even cause neighboring tissues to mix. 
weak but reproducible enrichment at contacts between ectoderm 
and mesoderm cells, scattered along the boundary (Fig. 7 G), sug-
gesting a potential locally controlled activation.
EpCAM levels affect the actin cytoskeleton
We hypothesized that the phenotypes observed may at least 
partly relate to changes in the actin–myosin cytoskeleton. For 
instance, one may expect that increased contractility would   
favor a stable tissue organization and ectoderm–mesoderm sepa-
ration, whereas decreased contractility would be permissive for 
cell movements, including tissue rearrangement such as epib-
oly, and cell mixing.
The influence of EpCAM levels on the actin cytoskeleton 
organization was examined by phalloidin staining of whole 
BCRs (Fig. 8, A–D), and the results confirmed by actin immuno-
staining on cryosections and live imaging of BCR-expressing 
RFP-utrophin (unpublished data): in wild-type BCRs, we ob-
served a thin irregular staining along the cell periphery, with 
larger patches located at corners between three cells (Fig. 8,   
A and C). These patches became more prominent in EpCAM-
depleted BCR, whereas the rest of the staining decreased (Fig. 8 B). 
The lateral punctuate pattern was restored, and the large patches 
at corners disappeared upon treatment with novel PKC inhibitor 
(Fig. 8 C), but not inhibitors of classical or atypical PKCs (un-
published data). In EpCAM-overexpressing BCRs, the patches 
were largely absent, and the cells became outlined by a smooth 
continuous staining (Fig. 8 D). Levels of phosphorylated myosin 
light chain detected by Western blot were reproducibly stronger 
in EpCAM-depleted tissues (Fig. 8 J), although only very par-
tially rescued by dominant-negative PKC-.
We examined cell-protrusive activity by live confocal   
microscopy BCRs expressing membrane-targeted GFP (mGFP). 
Consistent  with  the  pattern  reported  from  phalloidin-stained   
zebrafish embryos (Slanchev et al., 2009), the basal surface of 
BCR cells showed wide protrusions, which were globally less 
and more frequent in EpCAM MO and EpCAM overexpressing 
BCRs, respectively (Fig. 8, E–H). A closer look at these protru-
sions (Fig. 8, E–H) and at their dynamics (Fig. S4, quantifica-
tion presented in Fig. 8 I) revealed that EpCAM-depleted cells 
formed  in  fact  many  protrusions,  but  these  were  generally 
shorter, thinner, and most significantly short lived, as opposed 
to  the  extremely  large  and  stable  extensions  produced  by   
EpCAM-overexpressing cells.
We have recently analyzed the role of RhoA in the BCR 
assay and showed that blocking its activity on either side of the 
boundary by expression of a dominant-negative form causes 
mixing (unpublished data). We found here that activated RhoA 
could fully rescue the BCR–mesoderm boundary when co-
expressed with EpCAM, either in the BCR or in the mesoderm 
(Fig. 8, K and L), a result consistent with a role of EpCAM in 
antagonizing contractility.
Discussion
Our  results  reveal  important  aspects  of  EpCAM  biology   
and also provide interesting insights into the mechanisms   
of morphogenesis.JCB • VOLUME 191 • NUMBER 3 • 2010   656
Figure 8.  Effects of EpCAM depletion on actin cytoskeleton organization, myosin phosphorylation, and protrusive activity. (A–D) Confocal images of 
phalloidin-stained BCR explants. (A) Typical punctate phalloidin pattern (arrowheads) in control cells (COMO) with prominent accumulation at tricellular 
corners (large arrows). (B) Concentration at corners in EpCAM MO cells (large arrows), and decrease of the signal along the membranes. (C) Rescue of 
membrane staining and disappearance of the signal at corners upon coinjection of dominant-negative PKC- mRNA. (D) Homogenous membrane staining 
of EpCAM-overexpressing cells. (E–H) Live confocal images of the surface of membrane GFP-expressing BCR cells. Arrows: large protrusion. Arrowheads: 
small protrusions. (I) Quantitation of protrusive activity from time-lapse movies (see selected frames in Fig. S4). EpCAM MO-injected cells showed much 
fewer long-lasting protrusions than controls (P = 2,5E
07; Student’s t test) but many more short-lived extensions (P = 5,4E
07). Most protrusions emanating 
from EpCAM-overexpressing cells were long lived (P = 6,9E
06 compared with GFP controls). (J) Increased myosin light chain (MLC) phosphorylation in 
EpCAM MO BCRs, and partial rescue by coexpression of dominant-negative PKC-. (K and L) Rescue of tissue separation by coexpression of constitutively 
active RhoA. EpCAM mRNA (200 pg) was injected alone or with V14RhoA mRNA (25 pg). Numbers on top indicate total number of explants/number of 
experiments. *, P < 0.05 compared with EpCAM alone (Student’s t test).657 EpCAM signaling regulates morphogenesis • Maghzal et al.
results on the notochord–somitic boundary, where cells could 
sort on either side of the boundary independently of the strength 
of cadherin-mediated adhesion (Reintsch et al., 2005).
A physiological role for EpCAM as a bona fide cell adhe-
sion molecule remains to be established. In our experimental 
model, a “compacting” phenotype consistent with such func-
tion is observed only with the highest levels of expression, and 
could also result from strong cadherin stabilization rather than 
direct EpCAM adhesion. In addition to its role in epiboly,   
EpCAM is required to maintain epithelial tissue integrity in 
zebrafish (Slanchev et al., 2009), which has been interpreted as 
a result of EpCAM adhesive properties. We have observed a simi-
lar requirement for EpCAM in late (post-gastrulation) Xenopus 
embryos (unpublished data). Further studies are necessary to 
discriminate between direct roles in adhesion, or other possi-
ble function of the extracellular domains, dependent or inde-
pendent of homophilic binding (e.g., localization to membrane 
subdomains).  EpCAM  is  structurally  unique  among  CAMs.   
It rather resembles Notch in its general extracellular domain 
organization and has some distant homology with the plasmin-
ogen activator (Cirulli et al., 1998), thus molecules functioning 
in signaling and cell migration. In this context, EpCAM has 
been found to copurify with glycolipid-enriched lipid micro-
domains (Schmidt et al., 2004; Claas et al., 2005; Ladwein et al., 
2005), which have the potential to organize signaling complexes 
at the cell surface.
From the available data, EpCAM rather emerges as a cru-
cial signaling molecule, controlling two independent pathways, 
one regulating cell proliferation via nuclear activities, which   
involve -catenin–dependent transcripton (Maetzel et al., 2009), 
and this novel PKC-dependent role in morphogenetic processes. 
The remarkable “invasive” phenotype is obviously of interest 
for the understanding of EpCAM function in the context of 
adult tissues and metastasis. It is indeed tempting to speculate 
that high levels of EpCAM may similarly provide cancer cells 
with the ability to move more actively within a tissue (and/or a 
tumor), help to escape the tissue of origin, and perhaps even in-
vade other tissues.
Materials and methods
Embryo manipulations
Embryos were obtained as described previously (Danilchick et al., 1991). 
The  culture,  dissection,  and  injection  media  used  are  the  same  as  in 
Schohl and Fagotto (2003). Embryos were injected animally at the 2-cell 
stage (once in each blastomere) for BCR targeting, equatorially at the   
4-cell stage (once in each dorsal blastomere) for mesoderm targeting, and 
ventrally at the 4-cell stage (in one blastomere only) for the double-axis   
induction experiment. Embryonic staging was performed according to 
Nieuwkoop and Faber (1967). Dissections and assays were performed in 
MBS-H (modified barth solution containing: 88 mM NaCl, 1 mM KCl,   
2.4 mM NaHCO3, 0.82 mM MgSO4, 0.33 mM Ca(NO3)2, 0.41 mM 
CaCl2, 10 mM Hepes, and 10 µg/ml streptomycin sulfate and penicillin, 
pH 7.4 adjusted with NaOH).
Plasmids, mRNAs, and oligonucleotides
The following EpCAM cDNAs were cloned into pCS2+: EpCAM encodes 
full-length  EpCAM  (aa  1–315).  EpCAM-MT  corresponds  to  full-length   
EpCAM C-terminally fused to 6x myc tag, cloned into pCS2+MT. EpCAM-C 
(aa  1–278)  had  the  cytoplasmic  tail  replaced  by  the  6xmyc-tag  of 
pCS2+myc. E-EpCAM was constructed by fusing the signal sequence 
and the fifth extracellular repeat of C-cadherin (gift from P. Hausen,   
Note that EpCAM is also required for mesoderm morpho-
genesis at a slightly later stage (neurula), as we have observed 
failure of notochord cells to adopt their final arrangement in 
EpCAM-depleted embryos (unpublished data).
EpCAM appears to regulate cell movement via reorgani-
zation of the actin cytoskeleton, enabling cells to “flow” more 
freely within the tissue. Note that we still do not understand 
how cells “move” within these tissues. In our preliminary live 
images ectoderm cells seem to slide smoothly past each other 
(unpublished data), and we do not think that the protrusions 
formed along the inner surface of the ectoderm (Slanchev et al., 
2009 and unpublished data) are necessarily involved in epiboly. 
However, these superficial structures are striking and represent 
a useful source of information about the dynamic state of the 
cytoskeleton: in the absence of EpCAM, cells appear to be fro-
zen in a rigid, contracted state, unable to extend but very small 
and transient extensions. F-actin accumulates in clusters and, 
although we do not know their nature (the phospho-myosin sig-
nal was too weak at this stage to confirm with confidence its 
presence at these sites), it is tempting to speculate by analogy 
with other systems (Cavey et al., 2008) that they represent   
structures under tension involved in restricting cell rearrange-
ments. The increased total levels of phospho-myosin in EpCAM- 
depleted tissues and the fact that RhoA activation rescues   
separation (Fig. 8) are consistent with this hypothesis. With 
high EpCAM levels this tight actin organization is lost and large 
protrusions can extend, a process classically counteracted by 
Rho-induced contraction. Altogether, these observations sug-
gest an antagonism between EpCAM-dependent signaling and 
actin–myosin contractility.
The chemical activators and inhibitors showed effects on 
tissue mixing within minutes, demonstrating that this is a rather 
direct response to PKC modulation, even though the down-
stream events are likely to be complex considering the many 
targets of PKC. None of the other clones isolated in our screen 
had any obvious connection to PKC signaling (unpublished 
data). It should be noted, however, that the initial round of this 
relatively small screen (6,000 clones) involved pools of 50–60 
clones, which limited the amount of mRNA injected to 100 pg 
per clone. Thus, only molecules particularly active at interfering 
with tissue separation could be picked, a fact that emphasizes 
the remarkable properties of EpCAM.
Classical models of sorting at early embryonic boundaries 
have assumed asymmetric properties of the two apposing tis-
sues:  one  of  the  tissues  would  display  stronger  adhesion  or 
stronger cortical tension (Steinberg and McNutt, 1999; Krieg   
et al., 2008), or each tissue would express a different set of ad-
hesion molecules (Steinberg and Takeichi, 1994). Although such 
differences might indeed contribute to the ectoderm–mesoderm 
boundary, our data show that cells from either tissue can be   
induced to mix in a manner that appears perfectly symmetric 
according to several criteria (extracellular domain not required, 
PKC dependence, and RhoA rescue). Furthermore, mixing oc-
curs irrespectively of changes in cadherin surface expression in 
the ectoderm or in the mesoderm, indicating that the process is 
largely insensitive to differences in cell–cell adhesion. This sur-
prising observation is in fact quite consistent with our previous JCB • VOLUME 191 • NUMBER 3 • 2010   658
TV135; Carl Zeiss, Inc.) equipped with a 25x N.A. 0.8 water immersion 
objective (Carl Zeiss, Inc.) and a CCD camera (Retiga 2000R; Quantita-
tive Imaging Corporation), or an epifluorescence microscope (DM IRE2; 
Leica) equipped with a 20x/0.70 IMM Corr CS oil immersion objective 
and an ORCA-ER camera (Hamamatsu Photonics). Images were acquired 
using AnalySIS (Soft Imaging System GmbH) and MetaMorph (MDS Ana-
lytical Technologies) software. Large fields were reconstituted by collating 
pictures of adjacent regions (Schohl and Fagotto, 2002). Images of ex-
plants were acquired using a stereomicroscope (model MZ16F; Leica), a 
QImaging camera (MicroPublisher 3.3 RTV) and QCapture image acquisi-
tion software (Quantitative Imaging Corporation).
Quantification of rectilinearity of reconstituted boundaries
Images of the interface between BCR and mesoderm explants were divided 
in segments of 8-cell diameter. For each segment, the length of the inter-
face, measured using the R software (http://www.r-project.org), was di-
vided  by  the  length  of  the  straight  line  connecting  its  ends.  This  ratio 
provided a measurement for straightness of the boundary. Data collected 
from three independent experiments, with a total of 11–12 sandwiches per 
condition, were analyzed using ANOVA.
Phalloidin staining
Dissected BCRs were put inner layer facing down on the glass of a FluoroDish 
chamber (World Precision Instruments), then covered with a small piece   
of a Minicell-CM 0.4-µm membrane and a piece of coverglass secured 
with silicone grease and flattened by gently pressing the coverglass down. 
The membrane was inserted to improve diffusion during staining. BCRs 
were fixed in 4% formaldehyde in MBSX for 10 min, followed by 5 min 
permeabilization in 1% formaldehyde, 0.1% Triton X-100, 1 h incubation 
with blocking buffer (10% sheep serum), and overnight incubation with 
2U/ml Alexa 488–phalloidin (Invitrogen) in 10% sheep serum. Images 
from planes 3–5 µm inside the inner BCR surface were taken with a laser 
scanning microscope (LSM 510; Carl Zeiss, Inc.) with a 40x Neofluar NA 
1.3 oil objective.
Fluorescence live imaging
All experiments were performed at room temperature. Dissected BCRs 
were  flattened  on  glass  coated  for  30  min  with  1  µg/ml  fibronectin 
(Sigma-Aldrich) and blocked for 10 min with 1% bovine serum albumin. 
The inner BCR surface was imaged with a WaveFX spinning disc con-
focal  (Quorum  Technologies)  mounted  on  an  automated  microscope 
(model DMI6000B; Leica), with a 20x HC Plan-Apochromat CS, NA   
0.7 oil objective. Images were collected every 6 min with an EM CCD 
camera  (512  x  512  BT;  Hamamatsu  Photonics)  and  controlled  with 
Volocity 3DM software (PerkinElmer). For each condition, 5–6 cells were 
picked randomly in each image (4–5 images, from different BCRs, per 
condition, repeated in three independent experiments, with a total of   
70 cells per condition), and protrusions were followed over 10 frames to 
determine their life span. Statistical significance was determined using 
the Student’s t test.
Online supplemental material
Fig. S1 presents the amino acid sequences of Xenopus laevis EpCAMa 
and b pseudoalleles aligned with EpCAMs of representative vertebrate 
species. Fig. S2 A shows a diagram of the EpCAM constructs used 
in this study. Fig. S2, B and C, show that the C-terminally myc-tagged   
EpCAM has the same tissue-mixing activity as wild-type EpCAM (B), and 
that the mixing activity resides in specific residues of the cytoplasmic tail 
proximal to the transmembrane domain (C). Fig. S3 shows epiboly rescue 
experiments by various PKC inhibitors. Fig. S4 presents selected frames 
from live time-lapse movies illustrating the effect of EpCAM level protrusion 
dynamics. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201004074/DC1.
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Max-Planck-Institut für Entwicklungsbiologie, Tuebingen, Germany) to a frag-
ment of EpCAM lacking most of its extracellular domain (aa 265–315), 
cloned into pCS2+MT, containing a C-terminal 6x myc-tag; E247 and 
E253 (deletion of the cytoplasmic tail after aa 247 and aa 253) and 
E-EpCAM-NQ (point mutations K243N and K244Q) and E-QQ (R242Q 
and K244Q) were generated from E-EpCAM by site-directed mutagene-
sis. Other plasmids used: dnXTCF in pT7Ts (Molenaar et al., 1996), Myc-
eGFP (Reintsch et al., 2005) and -galactosidase in pCS2+ (Rupp et al., 
1994), dominant-negative PKC- (Kinoshita et al., 2003), and membrane-
targeted GAP43-eGFP.
All pCS-EpCAM plasmids were linearized with NotI and mRNAs 
were synthesized in vitro using SP6 RNA polymerase.
Morpholino  oligonucleotides:  Control  MO,  5-CCTCTTACCTCAGT-
TACAATTTATA-3 (human -globin mutant sequence); EpCAM1 MO, 5-CTT-
CATCCTCCAACAGACGGAACCC-3.  EpCAM2  MO,  5-GCCTCAGAG-
CTGTAACGAGCTGCAT-3; injected doses were 2 × 40 ng control MO or 
2 x 20 ng EpCAM MO1 + 20 ng EpCAM MO2 per embryo.
Antibodies
Antibodies  used  in  this  study  were  rabbit  anti-EpCAM  antibody  (raised 
against the cytoplasmic tail of EpCAM fused to GST), mouse anti–C-cadherin 
mAb 5G5 and rabbit anti–C-cadherin (generous gifts of B.M. Gumbiner, 
University of Virginia, Charlottesville, VA), mouse anti-myc tag mAb 9E10, 
mouse anti–-catenin mAb H102 (Santa Cruz Biotechnology, Inc.), mouse 
anti–-actinin antibody and rabbit anti-actin (Abcam) rabbit anti–phospho-
myosin  light  chain  and  anti–phospho-PKC  substrates  (Cell  Signaling 
Technology), and mouse anti-GFP mAb 3E6 (Invitrogen).
PKC agonists and antagonists
Concentrations used and suppliers: phorbol-12-myristate-13-acetate (PMA), 
32 nM; bisindolylmaleimide I (Bis1), 500 nM; calphostin C, chelery-
thrine chloride (ChelCl), 1 µM; Gö6976, 20 nM; PKC-20-28, 20 µM; 
Ro-32-0432, 30 nM; all from EMD. PKC- inhibitor peptide, 5 µg/ml, 
Santa Cruz Biotechnology, Inc.. PKC- peptide inhibitor, 2.5 µM, Enzo 
Life Sciences, Inc. Coleon U was a generous gift from Dr. M.F. Simões 
(University of Lisbon, Lisbon, Portugal). It was used at 5 µM for epiboly 
and 10 µM for mixing assays. They were all prepared from >400x stock 
solutions in DMSO.
Explants
Tissue  separation  assays.  The  tissue  separation  assays  were  performed 
largely as described in Wacker et al. (2000). One modification from the 
original protocol was the source of mesoderm. To ensure that the exact 
same region of the mesoderm would be dissected, independent of poten-
tial  effects  of  exogenously  expressed  proteins  on  involution,  we  used, 
rather than involuted mesoderm, earlier preinvoluted mesoderm dissected 
from stage 10+ embryos (Winklbauer et al., 2001). Non-involuted meso-
derm already displays strong separation behavior in the assay (Wacker   
et al., 2000). Statistical significance was determined using the Student’s   
t test, each experiment (2–3 BCRs and 8–15 explants) being treated as the 
experimental unit.
Sandwich assays and inner cell explants. Embryos were injected ani-
mally at the 2-cell stage. BCRs and mesoderm pieces were dissected 
from stage 10+ embryos. Sandwiches were gently pressed with a cover-
slip and cultured for 2 h in 1x MBS-H, then fixed in 4% paraformalde-
hyde, embedded in 2% low-melting agarose, permeabilized in 1x PBS + 
1% Triton X-100, infiltrated with fish gelatin, and processed for cryosec-
tioning  and  immunostaining  as  described  previously  (Fagotto  and 
Brown, 2008). Explants of inner ectodermal cells were prepared from 
stage 10 BCRs by peeling off the inner cell layer using an eyelash. The 
explants were placed in 1x MBS-H in 1% agarose-coated dishes and 
cultured for 2 h before fixation, agarose embedding, cryosectioning, 
and immunostaining.
Cell migration in sandwich assays were repeated in three indepen-
dent experiments. The percentage of cells in each category was calculated 
for each explant, and averaged for each experiment. The values were cal-
culated as average of the three experiments (the average from all explants 
combined gave virtually identical values). Statistical significance was   
determined using the Student’s t test, using each sandwich as the experi-
mental unit.
Immunofluorescence
Cryosectioning  and  immunofluorescence  were  performed  as  described 
previously (Schohl and Fagotto, 2002; Fagotto and Brown, 2008). Images 
were  obtained  using  either  an  epifluorescence  microscope  (Axiovert 659 EpCAM signaling regulates morphogenesis • Maghzal et al.
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